Endothelial-cell dysfunction is a critical initiating event in the pathogenesis of atherosclerosis. Although there is evidence to suggest that chylomicron remnants (CMRs), lipoproteins derived from the diet, influence endothelial-cell function to generate a pro-atherogenic phenotype, the mechanisms involved remain undefined. We have examined the effects of CMR-like particles (CMR-LPs) on human endothelial-cell function, focusing on the cyclo-oxygenase (COX) and nitric oxide synthase (NOS) pathways. CMR-LPs strongly enhanced the expression of the inducible cyclo-oxygenase COX-2 and increased prostacyclin synthesis in a biphasic manner. Studies with the COX-2-selective inhibitor NS-398 confirmed the COX-2 dependency of the later increase in prostanoid production. Pre-incubation with CMR-LPs reduced basal and thrombin-stimulated cGMP generation, whereas expression of endothelial NOS was not modified by remnant treatment.
Introduction
The interactions of lipoproteins with endothelial cells are key to our understanding of the early events in atheroma development and there has been much emphasis on the atherogenic role of endogenous lipids. In marked contrast, lipoproteins of dietary origin have been largely ignored in research in this area, and yet it is these particles, chylomicron remnants (CMRs), that carry fat from the diet to the tissues.
The primary step in atherosclerosis is the accumulation of lipoproteins in the subendothelial matrix at specific arterial sites. Endothelial dysfunction is likely to play a major role in the initiation of the disease and may enhance disease progression by promoting inflammation, smooth-musclecell proliferation, platelet activation and thrombus formation. There is growing support for a role for CMRs in the early events involved in atheroma development. Thus, CMRs enter the arterial wall as efficiently as low-density lipoproteins, accumulate in the sub-intimal space [1] [2] [3] and are taken up rapidly by macrophages [4, 5] , causing the extensive lipid accumulation associated with foam-cell formation. Impaired nitric oxide (NO) release is known to be one of the earliest signs of endothelial dysfunction [6, 7] and evidence is accumulating to suggest that CMR-like particles (CMR-LPs) impact on the NO pathway. For example, CMRs inhibit relaxation and potentiate vasoconstriction in an endothelium-dependent manner in rat aorta, and this is mediated in part by impaired NO production [3, 8, 9] . In addition, CMR-LPs of a similar Key words: chylomicron remnant, cGMP, cyclo-oxygenase, human endothelium, nitric oxide synthase, prostacyclin. Abbreviations used: ApoE, apolipoprotein E; CMR, chylomicron remnant; CMR-LP, CMR-like particle; COX, cyclo-oxygenase; ERK, extracellular-signal-regulated kinase; HUVEC, human umbilical vein endothelial cell; l-NAME, N G -nitro-l-arginine methyl ester; NOS, nitric oxide synthase; p38 mapk , p38 mitogen-activated protein kinase; PGI2, prostacyclin. 1 To whom correspondence should be addressed (e-mail mevans@rvc.ac.uk).
size, density and lipid composition to physiological CMRs have comparable effects on porcine coronary arteries, with CMR-LPs inhibiting basal NO production, and oxidized remnant particles suppressing both basal and agonist-induced NO formation [10] .
Prostaglandin and thromboxane A 2 generation by the endothelium is regulated by the expression and activities of cyclo-oxygenases (COXs), and eicosanoid production associated with inflammatory conditions depends upon enhanced expression of COX-2. Elevated COX-2 expression has been detected in atherosclerotic lesions, suggesting that COX-2 may be involved in the pathogenesis of this disorder [11] . The effects of CMRs on the COX pathway are unknown, but remnant-induced changes in COX-2 expression could allow these particles to influence the development of atherosclerosis through increased COX-dependent production of proatherogenic mediators.
The long-term aim of the present studies is to determine the mechanisms by which CMRs modify endothelial cell function and generate a pro-atherosclerotic phenotype in the vascular wall. To address this question, we have examined the effects of CMR-LPs on endothelial NO synthase (eNOS) and COX-1/2 expression in human umbilical vein endothelial cells (HUVECs) and have determined whether remnants modify endothelial production of the vasoactive mediators prostacyclin (PGI 2 ) and NO.
Materials and methods
CMR-LPs were prepared based on a method described by Diard et al. [12] . Briefly, a lipid mixture (50 mg) comprising 70% (w/w) trilinolein, 25% (w/w) phospholipid, 3% (w/w) cholesteryl oleate and 2% (w/w) cholesterol in 0.9% NaCl in Tricine buffer (20 mM, pH 7.4) was emulsified by sonication, and apolipoprotein E (ApoE) was transferred from human serum on to the appropriately sized particles [10] . The CMR-LPs resembled physiological CMRs in size, density and lipid composition, and had triacylglycerol/total cholesterol ratios of (4.01 ± 0.76):1 (n = 19 preparations).
HUVECs were isolated and cultured as described previously [13, 14] . For immunoblotting, HUVECs in 60-mm dishes were quiesced overnight and subsequently incubated with CMR-LPs or vehicle alone. Whole cell lysates were prepared and subjected to SDS/PAGE and immunoblotting procedures [14] using antibodies against COX-1, COX-2, eNOS, phospho-extracellular-signal-regulated kinase (ERK)1/2 or phospho-p38 mapk (p38 mitogen-activated protein kinase). PGI 2 production was quantified using either radioimmunoassay or a commercially available competitive enzyme immunoassay for 6-oxo-prostaglandin F 1α (Assay Designs Inc., Ann Arbor, MI, U.S.A.), the stable breakdown product of PGI 2 . NO production was assessed in the presence of 3-isobutyl-1-methylxanthine (500 µM) by measuring cGMP formation using enzyme immunoassay (Amersham Biosciences).
Results
In HUVECs exposed to CMR-LPs (20-80 µM) for times ranging between 1 and 24 h, COX-2 protein expression was markedly enhanced, with maximal effects observed after 8 h [1.40 ± 0.13 (S.E.M.); n = 9; P < 0.05; fold increase versus controls). Remnant-like particles that were devoid of human ApoE did not modify COX-2 expression in HUVECs. Densitometric analysis of immunoblots from four independent experiments showed that, in contrast with COX-2, COX-1 protein expression was not significantly affected by incubation with CMR-LPs for up to 24 h [0.91(± 0.03)-fold increase in remnant-treated cells versus controls at 8 h]. PGI 2 synthesis in HUVECs that were challenged with CMR-LPs was biphasic, with an early release evident between 30 min and 2 h (reaching significance at 1 h) and a later peak at 8 h. Late production of PGI 2 was concomitant with induction of COX-2 protein expression and was abolished by the COX-2 selective inhibitor, NS-398 (1 µM), whereas the early peak was unaffected (Figure 1 ). Acute (30 min) exposure of HUVECs to CMR-LPs or N G -nitro-L-arginine methyl ester (L-NAME; 100 µM) significantly reduced basal cGMP levels [control, 1.74 ± 0.38; CMR-LPs, 0.59 ± 0.11 (P < 0.05 versus controls); L-NAME, 0.30 ± 0.07 (P < 0.01 versus controls); n = 4] and also partially attenuated thrombin-induced cGMP formation. eNOS protein expression, in contrast, was not modified by CMR-LP treatment for up to 24 h. To define the signalling mechanisms triggered by CMR-LP treatment in HUVECs, we examined the effects of the particles on mitogen-activated protein kinase activation, focusing on ERK1/2 and p38 mapk . ERK1/2 was rapidly and consistently activated in response to CMR-LPs with activation occurring between 2 and 5 min of exposure. Phosphorylation of p38 mapk was not observed in all experiments and in those instances where activation was detected phosphorylation was minimal and delayed (30 min).
Discussion
Our results indicate that exposure of human endothelial cells to CMR-LPs upregulates the expression of COX-2 and that this is coincident with enhanced production of PGI 2 . In addition, increased COX-2 expression is dependent on the presence of human ApoE in the remnant-like particles, potentially implicating the involvement of an endothelial cell receptor that recognizes this protein. The rapid and sustained activation of ERK1/2 lends further support to the suggestion that the effects of CMR-LPs on HUVECs are receptor-mediated. The COX-2 dependency of the late remnant-induced prostanoid production was confirmed in experiments employing the COX-2-selective inhibitor NS-398. In contrast, the early PGI 2 release observed in remnant-stimulated cells was not affected by NS-398 treatment and is probably mediated through COX-1 activation. eNOS expression was not modified by CMR-LP treatment, indicating that changes in enzyme expression are unlikely to account for the remnantmediated decrease in basal cGMP observed in the present study, or in previous studies in whole vessels [3, 8, 10] . Exposure of HUVECs to CMR-LPs caused a rapid activation of the ERK1/2 family of mitogen-activated protein kinases, whose activation has been implicated in regulating COX-2 expression. In contrast, the effects of remnants on p38 mapk activation were miminal and inconsistent, suggesting that this pathway is unlikely to be a major regulator of CMR-LPinduced COX-2 expression. Our observations lend support to the hypothesis that the endothelium is an important target of CMR action in the vasculature and that dietary fats are able to modify endothelial cell function.
